Shares of Allergy Therapeutics plc (LON:AGY) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $13.21 and traded as high as $11.80. Allergy Therapeutics shares last traded at $11.60, with a volume of 4,237 shares trading hands.
Separately, FinnCap reissued a “corporate” rating on shares of Allergy Therapeutics in a research note on Thursday, July 11th.
The business’s 50 day moving average price is GBX 13.07. The stock has a market capitalization of $73.80 million and a PE ratio of -23.20. The company has a current ratio of 3.74, a quick ratio of 3.08 and a debt-to-equity ratio of 6.20.
Allergy Therapeutics plc engages in the research and development of allergy treatments. It sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees. The company's products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, and Venomil.
Recommended Story: What does an equal weight rating mean?
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.